Clinical Trial Update: Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the safety of two combination vaccines (DTPa-IPV/Hib and DTPa-HBV-IPV/Hib) in infants who had received hepatitis B vaccine; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• DTPa-HBV-IPV/Hib (Diphtheria and tetanus toxoids and acellular pertussis vaccine; Hepatitis B vaccine; Inactivated poliovirus vaccine; Haemophilus influenzae type b conjugate vaccine)
• DTPa-IPV/Hib (Diphtheria and tetanus toxoids and acellular pertussis vaccine; Inactivated poliovirus vaccine; Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Diphtheria | Phase 3 | Status: COMPLETED | Results posted: 2017-02-07